---
figid: PMC8047580__12291_2021_972_Fig5_HTML
figlink: pmc/articles/PMC8047580/figure/Fig5/
number: F5
caption: The overall hypothetical outline of integrated approach of distinct signalling axis
  for the stimulation of coagulatory mechanism during Covid-19 infection a. The infection
  of SARS-CoV-2 in the lungs generates a condition of hypoxia followed by the activation
  of PI3K/Akt/mTOR signallingwhich ultimately stimulates HIF-1 by forming a complex
  of HIF-1α and HIF-1β in combination with transactivators including CBP and P300,
  b. The activated HIF-1 complex turns on the direct expression of VEGF, essential
  for the process of angiogenesis, c. HIF-1 also triggers expression of NF-κB, a transcription
  factor by activating of IKK complex (IKKα, IKKβ and IKKγ) to phosphorylate the inhibitor
  of the classical pathway (IκBα), resulting degradation by its proteasomes. The transcriptionally
  active classical NF-κB heterodimer (p50:p65) then gets free to enter the nucleus
  and affect transcription of inflammatory genes, d. Simultaneously, HIF-1 also enhances
  apoptotic response by facilitating mitochondria to release cytochrome C and activates
  caspase 3. Likewise, HIF-1 can activate BNIP3 which binds Bcl-2/Bcl-xl and activates
  proapoptotic protein, Bax. HIF-1 also causes the stabilization of p53, required
  for apoptosis. JNK/SAPK  signalling activated by HIF-1 can also initiate apoptotic
   cascade through an unknown mechanism.  These signalling activation by HIF-1 can
   trigger the process of apoptosis, followd by PS externalization, Collectively,
  hypoxia induced mechanisms including inflammation, angiogenesis and apoptosis can
  further direct to the establishment of  thrombotic cascades. The dashed arrow (
  ) indicates mechanistic pathway undergo through numerous steps and solid arrow (
  ) illustrates transfer of signal from one active compound to another compound. Green
  arrow ( ) shows activation whereas red blunt arrow ( ) depicts inhibition. Abbreviations-
  Covid 19– coronavirus disease 19, SARS-CoV-2– severe acute respiratory syndrome
  coronavirus 2, NF-κB– nuclear factor- kappa B, IKK– inhibitor of nuclear factor-
  kappa-B kinase, IKKα– inhibitor of nuclear factor- kappaB kinase subunit alpha,
  IKKβ– inhibitor of nuclear factor- kappa-B kinase subunit beta, IKKγ– inhibitor
  of nuclear factor- kappaB kinase subunit gamma, HIFs– hypoxia inducible factors,
  HIFs-α and β– hypoxia inducible factors α and β, PI3K– phosphoinositide- 3-kinases,
  AKT/PKB– protein kinase B, mTOR– the mammalian target of rapamycin, CBP– CREB binding
  protein, p300– E1A binding protein 300, VEGF– vascular endothelial growth factor,
  BNIP3– B-cell lymphoma 2 (Bcl-2) adenovirus E1B interacting protein 3, Bcl-2– B-cell
  lymphoma 2, Bcl-xl– B-cell lymphoma xl, JNK– c-Jun NH2-terminal kinase, SAPK– stress
  activated protein kinase, PS– phosphatidylserine
pmcid: PMC8047580
papertitle: An Integrated Approach of the Potential Underlying Molecular Mechanistic
  Paradigms of SARS-CoV-2-Mediated Coagulopathy.
reftext: Anmol Goyal, et al. Indian J Clin Biochem. 2021 Apr 15 :1-17.
pmc_ranked_result_index: '91201'
pathway_score: 0.9572143
filename: 12291_2021_972_Fig5_HTML.jpg
figtitle: Overall hypothetical outline of integrated approach of distinct signalling axis
  for the stimulation of coagulatory mechanism during Covid-19 infection a
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8047580__12291_2021_972_Fig5_HTML.html
  '@type': Dataset
  description: The overall hypothetical outline of integrated approach of distinct
    signalling axis for the stimulation of coagulatory mechanism during Covid-19 infection
    a. The infection of SARS-CoV-2 in the lungs generates a condition of hypoxia followed
    by the activation of PI3K/Akt/mTOR signallingwhich ultimately stimulates HIF-1
    by forming a complex of HIF-1α and HIF-1β in combination with transactivators
    including CBP and P300, b. The activated HIF-1 complex turns on the direct expression
    of VEGF, essential for the process of angiogenesis, c. HIF-1 also triggers expression
    of NF-κB, a transcription factor by activating of IKK complex (IKKα, IKKβ and
    IKKγ) to phosphorylate the inhibitor of the classical pathway (IκBα), resulting
    degradation by its proteasomes. The transcriptionally active classical NF-κB heterodimer
    (p50:p65) then gets free to enter the nucleus and affect transcription of inflammatory
    genes, d. Simultaneously, HIF-1 also enhances apoptotic response by facilitating
    mitochondria to release cytochrome C and activates caspase 3. Likewise, HIF-1
    can activate BNIP3 which binds Bcl-2/Bcl-xl and activates proapoptotic protein,
    Bax. HIF-1 also causes the stabilization of p53, required for apoptosis. JNK/SAPK
     signalling activated by HIF-1 can also initiate apoptotic  cascade through an
    unknown mechanism.  These signalling activation by HIF-1 can  trigger the process
    of apoptosis, followd by PS externalization, Collectively, hypoxia induced mechanisms
    including inflammation, angiogenesis and apoptosis can further direct to the establishment
    of  thrombotic cascades. The dashed arrow ( ) indicates mechanistic pathway undergo
    through numerous steps and solid arrow ( ) illustrates transfer of signal from
    one active compound to another compound. Green arrow ( ) shows activation whereas
    red blunt arrow ( ) depicts inhibition. Abbreviations- Covid 19– coronavirus disease
    19, SARS-CoV-2– severe acute respiratory syndrome coronavirus 2, NF-κB– nuclear
    factor- kappa B, IKK– inhibitor of nuclear factor- kappa-B kinase, IKKα– inhibitor
    of nuclear factor- kappaB kinase subunit alpha, IKKβ– inhibitor of nuclear factor-
    kappa-B kinase subunit beta, IKKγ– inhibitor of nuclear factor- kappaB kinase
    subunit gamma, HIFs– hypoxia inducible factors, HIFs-α and β– hypoxia inducible
    factors α and β, PI3K– phosphoinositide- 3-kinases, AKT/PKB– protein kinase B,
    mTOR– the mammalian target of rapamycin, CBP– CREB binding protein, p300– E1A
    binding protein 300, VEGF– vascular endothelial growth factor, BNIP3– B-cell lymphoma
    2 (Bcl-2) adenovirus E1B interacting protein 3, Bcl-2– B-cell lymphoma 2, Bcl-xl–
    B-cell lymphoma xl, JNK– c-Jun NH2-terminal kinase, SAPK– stress activated protein
    kinase, PS– phosphatidylserine
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT3
  - AKT1
  - SETD2
  - BNIP3
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - TP53
  - CHUK
  - IKBKG
  - IKBKB
  - BAX
  - NFKBIA
  - MAPK9
  - MAPK8
  - MAPK10
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - PS
  - SARS-COV-2
  - SARS-CoV-2
genes:
- word: РІЗК/Akt/mTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: РІЗК/Akt/mTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: РІЗК/Akt/mTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: BNIP3
  symbol: BNIP3
  source: hgnc_symbol
  hgnc_symbol: BNIP3
  entrez: '664'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: р53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: Вах
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: IKB-a
  symbol: IKBA
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: IKB-a
  symbol: IKBA
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: JNK/SAPK
  symbol: SAPK
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK/SAPK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK/SAPK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK/SAPK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
chemicals:
- word: PS
  source: MESH
  identifier: C058647
diseases:
- word: SARS-COV-2
  source: MESH
  identifier: D045169
- word: SARS-CoV-2
  source: MESH
  identifier: C000657245
figid_alias: PMC8047580__F5
redirect_from: /figures/PMC8047580__F5
figtype: Figure
---
